Skip to content

Tolerance of camel*s milk and mare*s milk in cow*s milk protein allergy.

Tolerance of camel*s milk and mare*s milk in cow*s milk protein allergy. - The PAKA study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39043
Enrollment
31
Registered
2012-02-20
Start date
2012-01-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

voedselallergiëen cow's milk allergy

Interventions

Participants are randomized to receive increasing doses of either camel*s milk or mare*s milk in a standardized provocation test. One to four weeks later the participants who first received camel*s
participants who did not show allergic reactions to both milks will be randomized to receive camel*s milk or mare*s milk daily during four weeks, and the other milk during the four weeks thereafter

Sponsors

Benemel en Smits Kamelenmelk
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Cow's milk protein allergy proven by double-blind placebo-controlled provocation; >=3 years of age.

Exclusion criteria

Exclusion criteria: Experienced a life-threatening reaction to a food allergen; instable asthma.

Design outcomes

Primary

MeasureTime frame
Tolerance of camel*s and mare*s milk, as determined by provocation tests.

Secondary

MeasureTime frame
1. the minimum eliciting dose of camel*s milk and mare*s milk in CMA patients who do not tolerate these milk(s) in standardized food provocation tests; 2. medium-term (four weeks) tolerance of camel*s and/or mare*s milk in those participants who were negative in the provocation tests; 3. long-term (6-12 months) tolerance of camel*s and/or mare*s milk in those participants who were advised they could go on consuming the milk(s); 4. titer and affinity of specific IgE in serum to cow*s milk, camel*s milk and mare*s milk at the start of the study, and after four weeks of daily consumption of camel*s and/or mare*s milk; 5. the patients'experience with the consumption of camel's milk and mare's milk.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)